UY28260A1 - Combinación farmacéutica - Google Patents
Combinación farmacéuticaInfo
- Publication number
- UY28260A1 UY28260A1 UY28260A UY28260A UY28260A1 UY 28260 A1 UY28260 A1 UY 28260A1 UY 28260 A UY28260 A UY 28260A UY 28260 A UY28260 A UY 28260A UY 28260 A1 UY28260 A1 UY 28260A1
- Authority
- UY
- Uruguay
- Prior art keywords
- combination
- pharmaceutical combination
- eletriptan
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0308469A GB0308469D0 (en) | 2003-04-11 | 2003-04-11 | Pharmaceutical combination |
GB0312479A GB0312479D0 (en) | 2003-05-30 | 2003-05-30 | Pharmaceutical combination |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28260A1 true UY28260A1 (es) | 2004-11-30 |
Family
ID=33161221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28260A UY28260A1 (es) | 2003-04-11 | 2004-04-06 | Combinación farmacéutica |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1615635A1 (fr) |
JP (1) | JP2006522790A (fr) |
AR (1) | AR044009A1 (fr) |
BR (1) | BRPI0409127A (fr) |
CA (1) | CA2521902A1 (fr) |
MX (1) | MXPA05010070A (fr) |
NL (1) | NL1025908C2 (fr) |
PA (1) | PA8599901A1 (fr) |
PE (1) | PE20050086A1 (fr) |
TW (1) | TW200423929A (fr) |
UY (1) | UY28260A1 (fr) |
WO (1) | WO2004089365A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090299077A1 (en) * | 2008-05-22 | 2009-12-03 | Vinod Kumar Kansal | Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan |
IT1393700B1 (it) | 2009-04-22 | 2012-05-08 | F S I Fabbrica Italiana Sint | Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo |
JP6878021B2 (ja) * | 2016-02-02 | 2021-05-26 | 第一三共ヘルスケア株式会社 | トリプタンとアスコルビン酸を含有する医薬組成物 |
JP7237375B2 (ja) * | 2018-07-03 | 2023-03-13 | アクスサム セラピューティクス インコーポレイテッド | メロキシカムを含有する医薬組成物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
US5607951A (en) | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
US6488961B1 (en) | 1996-09-20 | 2002-12-03 | Ethypharm, Inc. | Effervescent granules and methods for their preparation |
GB9704524D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Composition |
GB9816556D0 (en) | 1998-07-30 | 1998-09-30 | Pfizer Ltd | Therapy |
GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
CO5261541A1 (es) * | 1999-05-14 | 2003-03-31 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de la migrana |
GB0018968D0 (en) * | 2000-08-02 | 2000-09-20 | Pfizer Ltd | Particulate composition |
GB0105131D0 (en) * | 2001-03-01 | 2001-04-18 | Pfizer Ltd | Compositions having improved bioavailability |
GB0129117D0 (en) * | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
CA2514875A1 (fr) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories International Srl | Formulations d'agonistes 5-ht selectifs a absorption rapide |
-
2004
- 2004-03-31 WO PCT/IB2004/001115 patent/WO2004089365A1/fr active Application Filing
- 2004-03-31 JP JP2006506461A patent/JP2006522790A/ja active Pending
- 2004-03-31 BR BRPI0409127-2A patent/BRPI0409127A/pt not_active IP Right Cessation
- 2004-03-31 CA CA002521902A patent/CA2521902A1/fr not_active Abandoned
- 2004-03-31 EP EP04724671A patent/EP1615635A1/fr not_active Withdrawn
- 2004-03-31 MX MXPA05010070A patent/MXPA05010070A/es active IP Right Grant
- 2004-04-06 UY UY28260A patent/UY28260A1/es not_active Application Discontinuation
- 2004-04-07 PE PE2004000356A patent/PE20050086A1/es not_active Application Discontinuation
- 2004-04-07 PA PA20048599901A patent/PA8599901A1/es unknown
- 2004-04-07 AR ARP040101192A patent/AR044009A1/es unknown
- 2004-04-08 NL NL1025908A patent/NL1025908C2/nl not_active IP Right Cessation
- 2004-04-09 TW TW093109936A patent/TW200423929A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PE20050086A1 (es) | 2005-03-01 |
CA2521902A1 (fr) | 2004-10-21 |
AR044009A1 (es) | 2005-08-24 |
EP1615635A1 (fr) | 2006-01-18 |
WO2004089365A1 (fr) | 2004-10-21 |
MXPA05010070A (es) | 2005-11-23 |
PA8599901A1 (es) | 2005-02-04 |
JP2006522790A (ja) | 2006-10-05 |
NL1025908C2 (nl) | 2005-11-22 |
BRPI0409127A (pt) | 2006-03-28 |
TW200423929A (en) | 2004-11-16 |
NL1025908A1 (nl) | 2004-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408396A (pt) | pelìculas de dissolução rápida, consumìveis por via oral, contendo agentes farmaceuticamente ativos | |
CY1116693T1 (el) | Συνδυασμος αζελαστινης και κυκλεσονιδης | |
NO20045434L (no) | En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom | |
CY1109119T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης που περιλαμβανουν λαμοτριγινη | |
ECSP099501A (es) | Formulaciones de dosis unitaria y métodos para el tratamiento de la trombosis con un inhibidor oral del factor xa | |
CL2004000643A1 (es) | Composicion farmaceutica que comprende un agonista de 5-ht 1b/1d y un inhibidor selectivo de ciclooxigenasa-2, util en el tratamiento de la migrana. | |
ECSP003652A (es) | TRATAMIENTO DE COMBINACION CON I1-1ra Y COMPUESTOS QUE INHIBEN EL PROCESAMIENTO Y LA LIBERACION DE I1-1 | |
CY1109523T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv | |
AR041089A1 (es) | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas | |
PA8669801A1 (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
UY28260A1 (es) | Combinación farmacéutica | |
GT200100149A (es) | Composicion de eletriptan en forma de particulas. | |
CR7648A (es) | Microcapsulas para la liberacion retardada y controlada del perindropil | |
BR9912588A (pt) | Prevenção de recorrência de enxaqueca | |
AR038305A1 (es) | Composicion farmaceutica dispersable oralmente de perindopril | |
PA8552301A1 (es) | Metodo para el tratamiento de insomnio primario | |
CR9074A (es) | Agente para la profilaxis o tratamiento del sindrome metabolico | |
DOP2004000871A (es) | Combinacion farmaceutica | |
DK1575362T3 (da) | Anvendelse af et acaricidpulver | |
AR057403A1 (es) | 4- anilino-3-quinolincarbonitrilos para el tratamiento del cancer | |
CL2004000751A1 (es) | Combinacion farmaceutica que contiene (a) eletripan, o una de sus sales, y (b) bicarbonato de sodio; composicion y producto farmaceutico que contiene a dicha combinacion; y su uso en la preparacion de un medicamento util para el tratamiento y la prev | |
UY27741A1 (es) | Supositorios de meloxicam | |
PE20010123A1 (es) | Agonistas del receptor 5ht1 y un inhibidor de la cox-2 o un aine para el tratamiento de la migrana | |
AR045724A1 (es) | Composicion farmaceutica orodispersable de un compuesto antitrombotico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150521 |